The use of the Delphi technique is prevalent across health sciences research, and it is used
to identify priorities, reach consensus on issues of importance and establish clinical …

Although these conditions are rare, a proportion of patients with interstitial lung diseases
(ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated …

Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who
have inexorable progression of pulmonary fibrosis despite treatment, which is known as the …

Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed …

Hypersensitivity pneumonitis (HP) is a complex syndrome caused by the inhalation of a
variety of antigens in susceptible and sensitized individuals. These antigens are found in the …

Background: Although the third most frequent interstitial lung disease, hypersensitivity
pneumonitis (HP) remains an enigmatic disease without clear diagnostic and therapeutic …

The past four decades have yielded advances in molecular biology allowing detailed
characterization of the cellular genome and the transcriptome: the complete set of RNA …

Rationale: Chronic hypersensitivity pneumonitis (CHP) is caused by an immune response to
antigen inhalation and is characterized by variable histopathological and clinical features. A …

Rationale: Rare genetic variants in telomere-related genes have been identified in familial,
idiopathic, and rheumatoid arthritis–associated pulmonary fibrosis. Short peripheral blood …